Skip to content

Mindset Reconditioning for Complex Regional Pain Syndrome: Safety and Efficacy

Mindset Reconditioning for Complex Regional Pain Syndrome: Safety and Efficacy - Mindset Reconditioning for CRPS

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41171
Enrollment
20
Registered
2014-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CRPS Post-traumatic Dystrophy Sudeck Dystrophy

Interventions

Mindset Reconditioning is a biopsychosocial approach to health and life style combining current best practices in cognitive behavioral and physical therapies. Its aim is operant reconditioning of th

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients between 18 and 80 years of age with CRPS of either upper or lower extremity according to the International Association for the Study of Pain (IASP) criteria between 3 and 24 months after initial injury will be selected for the study.

Exclusion criteria

Exclusion criteria: A potential subject with neurological or psychiatric disorders and/or CRPS in more than 1 extremity will be excluded from participation in this study.

Design outcomes

Primary

MeasureTime frame
Safety evaluation of the Mindset Reconditioning program is the primary aim of the study, and therefore, the primary outcome measures are chosen to detect changes at the level of severity of CRPS signs and symptoms during the phase of Mindset Reconditioning, including measures of body functions (pain, swelling/edema, temperature, skin color, and active range of motion), activities, participation and personal factors, according to the domains of the International Classification of Functioning, Disability and Health [ICF-WHO].

Secondary

MeasureTime frame
The selection of these outcome parameters will also provide data on the efficacy of this approach as a secondary aim of this study.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)